Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 065285

Expand all

DOXYCYCLINE (DOXYCYCLINE)
EQ 50MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065285
Product Number: 001
Approval Date: Dec 8, 2005
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 75MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065285
Product Number: 003
Approval Date: Jul 30, 2008
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 100MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065285
Product Number: 002
Approval Date: Dec 8, 2005
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 150MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065285
Product Number: 004
Approval Date: Jul 30, 2008
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information